Product Details
Onco-BCG 40 mg BCG for Immunotherapy I.P. In Pakistan
Onco-BCG 40 mg is a BCG-based immunotherapy product used in specialist-directed treatment, particularly for certain cases of non-muscle-invasive bladder cancer. BCG (Bacillus Calmette–Guérin) is a live attenuated strain of Mycobacterium bovis that stimulates a local immune response when administered into the bladder according to the approved product instructions.
This treatment helps the body's immune system target abnormal cells in the bladder lining and may reduce the risk of cancer recurrence in appropriate patients. Onco-BCG must be prescribed and administered by qualified healthcare professionals experienced in bladder cancer treatment.
Key Benefits
-
Bladder cancer immunotherapy: Used in specialist-directed treatment of certain non-muscle-invasive bladder cancers.
-
Immune system stimulation: Activates a local immune response in the bladder.
-
Recurrence risk reduction: May help reduce the risk of cancer returning in eligible patients.
-
Specialist-supervised treatment: Supports a structured treatment plan with appropriate monitoring.
-
Treatment planning: Allows the treating urologist or oncologist to tailor therapy according to the patient's diagnosis and clinical needs.
Ingredients
-
Active Ingredient: Bacillus Calmette–Guérin (BCG), a live attenuated bacterial preparation.
-
Strength: 40 mg, as stated in the product name.
-
Other Ingredients: Stabilizers and other formulation components may vary by manufacturer. Consult the official package insert for the complete composition.
Important: The exact biological potency, viable bacterial content, and formulation should be confirmed from the manufacturer's official label.
Specifications
-
Brand Name: Onco-BCG
-
Product Name: BCG for Immunotherapy I.P.
-
Strength: 40 mg
-
Product Type: Live attenuated BCG immunotherapy preparation
-
Therapeutic Category: Antineoplastic immunotherapy
-
Primary Use: Specialist-directed treatment of certain non-muscle-invasive bladder cancers
-
Administration Route: Intravesical (into the bladder), if specified by the approved product label
-
Dosage Form: Confirm from the product packaging
-
Packaging: Confirm vial and pack details from the manufacturer's label
-
Storage: Follow the manufacturer's instructions and official package insert
-
Availability: Subject to local stock and applicable prescription requirements in Pakistan
How to Use
-
Onco-BCG must be used only under the direction of a qualified urologist or oncologist.
-
A trained healthcare professional must prepare and administer the product according to the official instructions.
-
When indicated for bladder cancer, it is administered intravesically rather than by injection into a vein or muscle.
-
The treatment schedule and dose are determined by the treating specialist based on the diagnosis, treatment plan, and patient's condition.
-
Do not prepare, handle, or administer this live bacterial product yourself.
-
Tell the treating team about fever, urinary tract infection, blood in the urine, immune-system disorders, pregnancy, or medicines that suppress immunity before treatment.
-
Seek urgent medical attention for persistent high fever, chills, breathing difficulty, or severe or worsening symptoms after treatment.
